1 minute reading time (40 words)

Efficacy and Safety of VM202 in Painful Diabetic Peripheral Neuropathy - The HOPES Trial

Study Description: Brief Summary: A double-blind, randomized, placebo-controlled, single-center, 12-month phase 2 study designed to assess the safety and efficacy of VM202 as a replacement for opioid analgesics in opioid-tolerant subjects with painful diabetic peripheral neuropathy (DPN).

Related Posts

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More